Late Breaking Abstract - Exciting phase 1 data on RESP-X, a novel monoclonal antibody targeting a key virulence mechanism of Pseudomonas aeruginosa, with potential as a treatment to reduce exacerbations in non-CF bronchiectasis
Year: 2024
Type: conference-abstract
Authors: Colm Leonard, Victoria Savage, Nicola Ooi, Juergen Dobmeyer, Derek Lindsay, Lauren Walker, Richard Fitzgerald
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4404104045